NBC Bay Area reported that Mochi Health worked with Aequita and that state officials said it had closed [3].
Aequita Pharmacy was a compounding pharmacy in Kirkland, Washington that made compounded GLP-1 drugs for telehealth companies.
What Aequita Pharmacy was
Washington's Department of Health lists Aequita Pharmacy LLC, license PHAR.CF.61458335, at 12825 NE 126th Place, Kirkland, WA, and says it compounded GLP-1 drugs such as semaglutide and tirzepatide [1]. NBC Bay Area reported that inspectors said it shipped about 20,000 prescriptions a week at one point [3].
503A or 503B?
Aequita was a state-licensed pharmacy regulated by Washington's pharmacy commission [1]. It is not on FDA's registered outsourcing facility list, checked Oct 24, 2026 [4].
State action
On Mar 13, 2025, the commission issued a Limited Stop Service on the license, which bars compounding and the dispensing, delivery or distribution of compounded products in Washington until the matter is resolved [1]. The state alleged the pharmacy "failed to develop and implement a commission-approved plan of correction" and used "untrained and unqualified staff to perform sterile compounding" [1].
NBC Bay Area reported on Jun 4, 2026 that the state issued a Notice of Immediate Jeopardy after a March 2025 inspection, and that state officials said Aequita closed in April [3]. We did not find a primary state record of the closure.
FDA record
| Date | Action | Details |
|---|---|---|
| Jul 18, 2025 | Recall started, Class II | 13 entries for compounded semaglutide with cyanocobalamin and tirzepatide with niacinamide vials, reason "Lack of Processing Controls" [2] |
| Aug 13, 2025 | FDA enforcement report | Recall listed as ongoing [2] |
| Any date | Warning letters | None found on FDA's compounding actions page under Aequita [5] |
Which providers we review used it
NBC Bay Area reported that Mochi Health worked with Aequita on compounded GLP-1s and still offers compounds through other pharmacies [3]. We rate Mochi Clean, since the state action was against the pharmacy, not Mochi; read our Mochi Health review. FDA's letters to telehealth companies are on our FDA warning letter tracker.
If you still have Aequita vials
Check the lot against the recall listing and ask your prescriber or pharmacist what to do with recalled product [2]. Do not switch to research-use-only vials as a replacement.
Any drug any pharmacy compounds is not FDA-approved. FDA says it does not check the safety, effectiveness or quality of compounded drugs before they are sold [6]. That holds for compounded semaglutide and compounded tirzepatide too.
- Read the label. The pharmacy name and address on the vial or box should match a pharmacy you can look up. FDA lists a pharmacy name on the label that you think might be fraudulent as a red flag [7].
- Check the license with the state board. FDA's BeSafeRx page links every state board of pharmacy license search [8]. Look up the pharmacy in its home state and in the state where you live.
- Check the website with NABP. The National Association of Boards of Pharmacy runs a Safe Site Search on Safe.Pharmacy and says a safe online pharmacy accepts only valid prescriptions, is licensed where it is located and where you live, and has a pharmacist you can reach [9].
- Never buy research-use-only vials. They are not legal for human use and are not pharmacy products.
- Report problems. FDA asks people to report side effects or quality problems with any medicine to MedWatch [7]. For a medical emergency, call 911.
Other pharmacies are on all the pharmacies we checked. Legal options are compared on our GLP-1 program page.
Questions people ask
Is Aequita Pharmacy legit?
Did Aequita Pharmacy recall semaglutide?
Yes. FDA recall records show a Class II recall started Jul 18, 2025 for compounded semaglutide and tirzepatide vials over "Lack of Processing Controls" [2].
Did Mochi Health use Aequita Pharmacy?
NBC Bay Area reported on Jun 4, 2026 that Mochi worked with Aequita to make compounded GLP-1s and now uses other pharmacies [3].
Where was Aequita Pharmacy?
Washington's Department of Health lists it at 12825 NE 126th Place, Kirkland, WA, license PHAR.CF.61458335 [1].
Why did Washington stop Aequita from compounding?
The state alleged it failed to carry out an approved plan of correction and used untrained and unqualified staff for sterile compounding, per the Mar 13, 2025 notice [1].
Medical review: pending. A licensed clinician has not yet reviewed this page.
Sources
9 cited
- Pharmacy Quality Assurance Commission issues Limited Stop Service on license of pharmacy (release 25-034). Washington State Department of Health, Mar 13, 2025.
- openFDA drug enforcement (recall) records: recalling firm Aequita Pharmacy. FDA (openFDA), Oct 24, 2026.
- Mochi Health weight loss drugs face scrutiny. NBC Bay Area, Jun 4, 2026.
- Registered outsourcing facilities. FDA, 2026-10-22 (accessed 2026-10-24).
- Compounding: inspections, recalls, and other actions. FDA, 2026-10-22 (accessed 2026-10-24).
- Compounding and the FDA: questions and answers. FDA, 2025-09-16 (accessed 2026-10-24).
- FDA's concerns with unapproved GLP-1 drugs used for weight loss. FDA, 2026-10-01 (accessed 2026-10-24).
- Locate a state-licensed online pharmacy. FDA BeSafeRx, 2024-11-13 (accessed 2026-10-24).
- Find safe online pharmacies. National Association of Boards of Pharmacy (Safe.Pharmacy), 2026-07-01 (accessed 2026-10-24).
This page is general information, not medical advice. Talk with a licensed clinician about your own care.